Thousand Oaks-based Amgen issued a voluntary recall of its chronic heart failure drug, Corlanor, due to contamination concerns. Announced late June, Amgen recalled almost 1 million bottles of Corlanor after the company detected the presence of a foreign substance in batches of the medicine made in Italy, according to a filing Amgen made with the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
